Local Institution - 103

Chicago, Illinois 60637

0 studies enrolling now · 2 studies all time

What they study most

Leukemia, Myeloid, Acute, Lymphoma, Non-Hodgkin

Studies at this site

• A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) — Running, not enrolling